Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000198 · ClinicalTrials.gov registry record · Phase 1
Piracetam for Treatment of Cocaine Addiction - 3
A Phase 1 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00000198: Completed Phase 1 study, sponsored by University of Pennsylvania.
NCT00000198 is a Phase 1 study that has completed, run by University of Pennsylvania. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000198, a Phase 1 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this study is to evaluate the effects of IV cocaine administration in cocaine dependent subjects maintained on piracetam while they are residing in an inpatient addictions treatment research unit and to subsequently follow these patients in an eight week open label assessment of piracetam in an outpatient treatment program.
Interventions
- DRUG Piracetam
Trial Details
| Field | Value |
|---|---|
| Start Date | 1996-10 |
| Est. Completion | 1997-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000198
The ClinicalTrials.gov registry entry for NCT00000198 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Piracetam is the first listed.
NCT00000198 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000198 about?
NCT00000198 is a clinical study titled "Piracetam for Treatment of Cocaine Addiction - 3". The purpose of this study is to evaluate the effects of IV cocaine administration in cocaine dependent subjects maintained on piracetam while they are residing in an inpatient addictions treatment research unit and to subsequently follow these patients in an eight week open label assessment of pirac...
What is the current status of trial NCT00000198?
This trial is currently completed. It is a Phase 1 study. The study started on 1996-10. Estimated completion is 1997-10.
What interventions are being tested in trial NCT00000198?
The interventions under investigation include: Piracetam (DRUG).
Who is sponsoring clinical trial NCT00000198?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.